Coppell Advisory Solutions LLC Fate Therapeutics Inc Transaction History

Coppell Advisory Solutions LLC

  • $680 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$2.02 - $5.04 $9,443 - $23,562
-4,675 Reduced 52.74%
4,190 $42.3 Million
Q2 2023

Aug 17, 2023
BUY
$4.76 - $6.59 $42,197 - $58,420
8,865 New
8,865 $42.4 Million
Q1 2023

May 19, 2023
SELL
$4.24 - $11.12 $17,765 - $46,592
-4,190 Closed
0 $0
Q4 2022

May 19, 2023
BUY
$9.86 - $23.83 $41,313 - $99,847
4,190 New
4,190 $42.3 Million

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $235M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email